Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options

The Aging Male, 08/16/2011

Benign prostatic hyperplasia (BPH) is a medical condition affecting a wide range of the aging male population resulting in various degrees of lower urinary tract symptoms (LUTS). A variety of medical therapies and minimally invasive BPH treatment modalities are available. Medical therapy includes αα1 blockers, 5 αα reductase inhibitors and combination therapy. In this article, current treatment options for BPH are reviewed with respect to their indications, long-term safety and efficacy in relieving BPH related LUTS. The selection of the type of BPH treatment should be based on the physician's experience, patient's co-morbidities as well as the prostate size and clinical disease progression.

Print Article Summary Cat 2 CME Report